Solutions for
- - - Aiosyn develops software solutions that use state-of-the-art computational pathology technology. Our AI-powered pathology algorithms are integrated in standard pathology workflows to enable diagnostics and clinical studies anywhere and anytime.
- - - Clinical Diagnostics
      
      We develop algorithms that improve the digital pathology workflow and certified clinical diagnostic algorithms that augment pathologists.
    - Learn more
  - - Life Sciences
      
      We support CROs and biopharma with AI-powered solutions to identify novel pathology-based biomarkers that can accelerate drug development.
    - Learn more
  - - AI & Data Providers
      
      We enable AI and data providers to ensure the use of only high-quality, artifact-free images.
    - Learn more
AI Pathology Software
- - - We specialize in deep learning solutions for pathologists, focusing on cancer and chronic kidney disease biomarkers. Our AI-powered technology improves the digital pathology workflow and facilitates informed decision-making in drug development and clinical diagnostics.
- - - Automated Quality Control
      
      We provide an AI-powered solution for automated quality control of digital histology slides in the pathology workflow.
    - Learn more
  - - Mitotic figure counting
      
      We provide an AI-powered solution to aid clinical and research labs with the identification of mitotic figures in H&E sections.
    - Learn more
  - - NephroPath platform
      
      Aiosyn’s NephroPath platform harnesses AI-powered computational pathology algorithms that provide objective quantification of kidney lesion scores.
    - Learn more
Services
- External Digital Slide Quality Assessment
- Kidney Analysis Services
News & Resources
About

Home » Team » Patrick de Boer

Patrick de Boer

CHIEF EXECUTIVE OFFICER

Patrick de Boer

Patrick is co-founder and Chief Executive Officer of Aiosyn. He studied Health Sciences and followed a MSc Management and Entrepreneurship in Life Sciences at the VU University. Patrick founded a European life science consulting company specialized in strategy and financing services for medtech and biotech companies (sold in 2018). Early 2020, he co-founded a medical diagnostics company (now part of Microbe&Lab) that provides tests for infectious diseases (e.g., Covid-19) and a platform for at-home testing and health programs for consumers and employers. In 2021, he co-founded Aiosyn in which he will take AI-powered pathology algorithms to patients and doctors.

Patrick is an enthusiastic amateur cyclist and likes to spend time in the mountains.

Education

MS in Policy Analysis and Entrepreneurship in the Health and Life Sciences (MPA)

Vrije Universiteit Amsterdam | 2007 – 2009

BSc in Health Sciences

Vrije Universiteit Amsterdam | 2006 – 2008

Experience

CEO and Co-founder

Advisor digital health

Holland Startup | 2019 – 2022

Commercial Director

Ttopstart | 2018 – 2020

Co-founder

Ttopstart | 2009 – 2018

Guest Lecturer Business Management in Health and Life Sciences

Vrije Universiteit Amsterdam | 2010 – 2017

CEO a.i.

DualTpharma | 2013

Aiosyn develops software solutions that use state-of-the-art computational pathology technology. Our AI-powered pathology algorithms are integrated in standard pathology workflows to enable diagnostics and clinical studies anywhere and anytime.

Clinical Diagnostics

Life Sciences

AI & Data Providers

We specialize in deep learning solutions for pathologists, focusing on cancer and chronic kidney disease biomarkers. Our AI-powered technology improves the digital pathology workflow and facilitates informed decision-making in drug development and clinical diagnostics.

Automated Quality Control

Mitotic figure counting

NephroPath platform

Patrick de Boer

CHIEF EXECUTIVE OFFICER

Patrick de Boer

Education

Experience

More articles from this author

Aiosyn raises EUR 2 million to develop AI-powered algorithms to support pathologists with clinical diagnostics

Aiosyn haalt 2 miljoen euro op om AI-algoritmes te ontwikkelen die pathologen ondersteunen bij klinische diagnostiek

Aiosyn and Radboudumc are the first in the Netherlands to implement AI in the clinical pathology workflow

LUMO Labs leads pre-seed round in Aiosyn’s AI-powered diagnostics platform

Investering in Aiosyns AI-platform voor efficiënte en precieze diagnose

New start-up Aiosyn will bring AI research into pathology diagnostics

Start-up Aiosyn ontwikkelt AI-innovaties voor de patholoog

Digital workflow as an essential prerequisite for AI in pathology – AI for Life Podcast

Aiosyn develops software solutions that use state-of-the-art computational pathology technology. Our AI-powered pathology algorithms are integrated in standard pathology workflows to enable diagnostics and clinical studies anywhere and anytime.

Clinical Diagnostics

Life Sciences

AI & Data Providers

We specialize in deep learning solutions for pathologists, focusing on cancer and chronic kidney disease biomarkers. Our AI-powered technology improves the digital pathology workflow and facilitates informed decision-making in drug development and clinical diagnostics.

Automated Quality Control

Mitotic figure counting

NephroPath platform